CD4 receptor antagonist

This page covers all CD4 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD4.

Targets

CD4

Marketed (1)

• A4 · Breath of Life International Pharma Ltd · Infectious Disease
  A4 is a monoclonal antibody that targets the CD4 receptor.

Phase 3 pipeline (1)

• ibalizumab-uiyk · TaiMed Biologics Inc. · Infectious Disease
  Ibalizumab-uiyk is a monoclonal antibody that binds to the CD4 receptor on T cells, preventing HIV entry and replication.